Synapse

← PLoS Currents

Papers in PLoS Currents

Page 9 · newest first

  1. Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic micePLoS Currents · 2010
  2. VirSim - a Model to Support Pandemic Policy MakingPLoS Currents · 2010
  3. Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and AmpakinesPLoS Currents · 2010
  4. Genetic Testing for CYP450 Polymorphisms to Predict Response to Clopidogrel: current evidence and test availabilityApplication: PharmacogenomicsPLoS Currents · 2010
  5. MRI T2 Hypointensities in basal ganglia of premanifest Huntington's diseasePLoS Currents · 2010
  6. Genetic content of Influenza H3N2 vaccine seedsPLoS Currents · 2010
  7. KRAS mutational analysis for colorectal cancerApplication: PharmacogenomicPLoS Currents · 2010
  8. Tumor Gene Expression Profiling in Women with Breast CancerTest Category: PrognosticPLoS Currents · 2010
  9. Oncotype DX tumor gene expression profiling in stage II colon cancerApplication: Prognostic, risk predictionPLoS Currents · 2010
  10. Evaluation of Histone Deacetylases as Drug Targets in Huntington’s Disease modelsStudy of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.PLoS Currents · 2010
  11. The Early Transmission Dynamics of H1N1pdm Influenza in the United KingdomPLoS Currents · 2010
  12. Quantifying the transmissibility of human influenza and its seasonal variation in temperate regionsPLoS Currents · 2010
  13. A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virusPLoS Currents · 2010
  14. The severity of pandemic H1N1 influenza in the United States, April – July 2009PLoS Currents · 2010
  15. Public preparedness guidance for a severe influenza pandemic in different countries: a qualitative assessment and critical overviewPLoS Currents · 2010
  16. Lymphocyte to monocyte ratio as a screening tool for influenzaPLoS Currents · 2010
  17. Structure and Receptor binding properties of a pandemic H1N1 virus hemagglutininPLoS Currents · 2010
  18. Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza SeasonsPLoS Currents · 2010
  19. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010PLoS Currents · 2010
  20. Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic.PLoS Currents · 2010
  21. Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 InfluenzaPLoS Currents · 2010
  22. Pandemic influenza 2009 on Réunion Island: A mild wave linked to a low reproduction numberPLoS Currents · 2010
  23. Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in JapanPLoS Currents · 2009
  24. Absolute Humidity and the Seasonal Onset of Influenza in the Continental USPLoS Currents · 2009
  25. Optimizing allocation for a delayed influenza vaccination campaignPLoS Currents · 2009
  26. Seasonal Influenza Vaccine Allocation in the Canadian Population during a PandemicPLoS Currents · 2009
  27. H1N1 vaccination and adults with underlying health conditions in the USPLoS Currents · 2009
  28. Modeling the critical care demand and antibiotics resources needed during the Fall 2009 wave of influenza A(H1N1) pandemicPLoS Currents · 2009
  29. Predispensing of Antivirals to High-Risk Individuals in an Influenza PandemicPLoS Currents · 2009
  30. Estimate of Novel Influenza A/H1N1 cases in Mexico at the early stage of the pandemic with a spatially structured epidemic modelPLoS Currents · 2009
  31. Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impactPLoS Currents · 2009
  32. Can Reactive School Closures help critical care provision during the current influenza pandemic?PLoS Currents · 2009
  33. Reassortment Patterns in Swine Influenza VirusesPLoS Currents · 2009
  34. Green tea catechins inhibit the endonuclease activity of influenza A virus RNA polymerasePLoS Currents · 2009
  35. Economic Cost and Health Care Workforce Effects of School Closures in the U.S.PLoS Currents · 2009
  36. Behavioural responses to influenza pandemicsWhat do we know?PLoS Currents · 2009
  37. Social versus independent interest in 'bird flu' and 'swine flu'PLoS Currents · 2009
  38. Mortality and morbidity burden associated with A/H1N1pdm influenza virusWho is likely to be infected, experience clinical symptoms, or die from the H1N1pdm 2009 pandemic virus ?PLoS Currents · 2009
  39. Reconstructing the initial global spread of a human influenza pandemicA Bayesian spatial-temporal model for the global spread of H1N1pdmPLoS Currents · 2009
  40. Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in micePLoS Currents · 2009
  41. Spatiotemporal dynamics in the early stages of the 2009 A/H1N1 influenza pandemicPLoS Currents · 2009
  42. The early molecular epidemiology of the swine-origin A/H1N1 human influenza pandemicPLoS Currents · 2009
  43. The Contribution of the PB1-F2 Protein to the Fitness of Influenza A Viruses and its Recent Evolution in the 2009 Influenza A (H1N1) Pandemic VirusPLoS Currents · 2009
  44. First estimation of direct H1N1pdm virulenceFrom reported non consolidated data from Mauritius and New CaledoniaPLoS Currents · 2009
  45. Swine origin influenza A (H1N1) virus and ICU capacity in the USAre we prepared?PLoS Currents · 2009
  46. Adaptive vaccination strategies to mitigate pandemic influenzaMexico as a case studyPLoS Currents · 2009
  47. Evolutionary Dynamics of N-Glycosylation Sites of Influenza Virus HemagglutininPLoS Currents · 2009
  48. Transmission of influenza virus in temperate zones is predominantly by aerosol, in the tropics by contactA hypothesisPLoS Currents · 2009